Biotech ETFs

SPDR S&P Biotech ETF XBI with $8.10B in assets. In the last trailing year, the best-performing Biotechnology ETF was LABU at 45.49%. The most recent ETF launched in the Biotechnology space was the YieldMax MRNA Option Income Strategy ETF MRNY on 10/23/23.

' data-prop-topic-name='Biotech' data-prop-topic-relatedTopics='' >
SPDR S&P Biotech ETF XBI with $8.10B in assets. In the last trailing year, the best-performing Biotechnology ETF was LABU at 45.49%. The most recent ETF launched in the Biotechnology space was the YieldMax MRNA Option Income Strategy ETF MRNY on 10/23/23.

' data-prop-topic-name='Biotech' data-prop-topic-relatedTopics='' >

Top News Stories

View All
Biotechnology

XBI, Biotech ETFs Sail With Viking’s VKTX

Kent Thune | Feb 29, 2024
Features

Booming Health-Care Spending Supports Industry ETFs

ETF Report | Oct 02, 2023
Daily Hot Reads

Hot Reads: Passive Funds to Overshadow Active in US

Heather Bell | Jan 25, 2023
News

Biotech May Offer Compelling Value

Andrew Hecht | Dec 19, 2022
News

Biotech Stocks: High Risks, High Alpha?

Nicolas Rabener | Jun 06, 2022

Latest News

Invesco Plans New Managed Futures ETF
Daily ETF Flows
etf.com Staff | Jan 14, 2025
Bear market
Economy
Kent Thune | Jan 14, 2025
Charles Schwab
Active Management
DJ Shaw | Jan 14, 2025
Investing - 2025 Market Prediction
Podcasts
Advisor Insider Podcast | Jan 14, 2025
Homebuilding
California Wildfires
Jeff Benjamin | Jan 14, 2025
Bond Ladder - Investing - Growth
Bond ETFs
Sumit Roy | Jan 14, 2025

Market News

View All
Market News - Topics
Invesco Plans New Managed Futures ETF
Daily ETF Flows
etf.com Staff | Jan 14, 2025
Bear market
Economy
Kent Thune | Jan 14, 2025